Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03478553

The Genetics of Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, a Disease Initiated by Mucociliary Dysfunction

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.

Detailed description

The purpose of this study is to explore genetic factors associated with the development of pulmonary fibrosis. The investigators aim is to identify and explore genetic loci that affect development of pulmonary fibrosis and also explore related environmental exposures. Idiopathic pulmonary fibrosis (IPF) is one of the interstitial lung diseases under the broader umbrella of idiopathic interstitial pneumonias (IIP). The investigators hypothesize that inherited genetic factors are associated with pulmonary fibrosis. To investigate the genetics of pulmonary fibrosis, the investigators plan to enroll individuals with pulmonary fibrosis and their family members.

Conditions

Interventions

TypeNameDescription
OTHERBlood drawBlood draw
OTHERQuestionnairePulmonary Fibrosis Questionnaire

Timeline

Start date
2018-01-18
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2018-03-27
Last updated
2025-03-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03478553. Inclusion in this directory is not an endorsement.